Evidence map›Paper›PMID 33219329›Full record

ReviewNature reviews. Clinical oncology2021

Rising incidence of early-onset colorectal cancer - a call to action.

Naohiko Akimoto, Tomotaka Ugai, Rong Zhong, Tsuyoshi Hamada, Kenji Fujiyoshi, Marios Giannakis, Kana Wu, Yin Cao, Kimmie Ng, Shuji Ogino

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Clinical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06342401 (Development and Validation fo an Exosome-Based and Machine Learning Powered Liquid Biopsy for the Detection of Early-Onset Colorectal Cancer), which is not on this map. Cited by 464 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
464citing papers in PubMed, 3 pooled it
24.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06342401 recruitingnot on this mapstarted 2023, after this paper: background citation

Development and Validation fo an Exosome-Based and Machine Learning Powered Liquid Biopsy for the Detection of Early-Onset Colorectal Cancer

TypeobservationalSponsorCity of Hope Medical CenterRan2023 to 2028Enrolled400ConditionsColorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma, Colorectal Cancer Stage IArmsENCODE
3 · Its place in the literature

Who cites it

464 citing papers in PubMed, 3 syntheses or guidelines pooled it, 656 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

404 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Naohiko Akimoto *Program in Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Tomotaka Ugai *Program in Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Rong Zhong *Program in Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Tsuyoshi HamadaDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Kenji FujiyoshiProgram in Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Marios GiannakisDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Kana WuDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Yin CaoDivision of Public Health Sciences, Department of Surgery, Washington University in St. Louis, St. Louis, MO, USA.
Kimmie NgDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Shuji OginoProgram in Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. sogino@bwh.harvard.edu.ORCID http://orcid.org/0000-0002-3909-2323
Brigham and Women's Hospital · USBroad Institute · USDana-Farber Cancer Institute · USKurume University · JPThe University of Tokyo · JPWashington University in St. Louis · US

Funding

Spatial Immunopathological Epidemiology of Colorectal Adenoma-Carcinoma SpectrumR01CA248857 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Jonathan Andrew Nowak, Shuji Ogino · 2020 to 2026
$6.6M
Accelerating Transdisciplinary Epidemiology of Colorectal CancerR35CA197735 · NCI · DANA-FARBER CANCER INST · PI OGINO, SHUJI · 2015 to 2021
$6.0M
Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biologyR01CA205406 · NCI · DANA-FARBER CANCER INST · PI Kimmie Ng · 2017 to 2026
$4.9M
Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasiaR37CA246175 · NCI · WASHINGTON UNIVERSITY · PI Yin Cao · 2020 to 2026
$3.9M
Integrated Micro Scale transcriptional profiling of cell communication networksR33CA160344 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI ALARID, ELAINE T, BEEBE, DAVID J · 2011 to 2013
$818k
Integrating diet, lifestyle and tumor tissue molecular subtyping to study the role of adolescent calcium intake on the risk of early onset colorectal neoplasiaR21CA230873 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI OGINO, SHUJI, WU, KANA · 2018 to 2019
$427k
Early life risk factors and risk of colorectal neoplasiaR03CA197879 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WU, KANA · 2015 to 2016
$162k
Cancer Research UK 27140Cancer Research UK C10674/A27140NCI NIH HHS R01 CA205406NCI NIH HHS R01 CA248857NCI NIH HHS R03 CA197879NCI NIH HHS R21 CA230873NCI NIH HHS R33 CA160344NCI NIH HHS R35 CA197735NCI NIH HHS R37 CA246175
6 · The paper itself

Abstract

The incidence of early-onset colorectal cancer (CRC), which occurs in individuals <50 years of age, has been increasing worldwide and particularly in high-income countries. The reasons for this increase remain unknown but plausible hypotheses include greater exposure to potential risk factors, such as a Western-style diet, obesity, physical inactivity and antibiotic use, especially during the early prenatal to adolescent periods of life. These exposures can not only cause genetic and epigenetic alterations in colorectal epithelial cells but also affect the gut microbiota and host immunity. Early-onset CRCs have differential clinical, pathological and molecular features compared with later-onset CRCs. Certain existing resources can be utilized to elucidate the aetiology of early-onset CRC and inform the development of effective prevention, early detection and therapeutic strategies; however, additional life-course cohort studies spanning childhood and young adulthood, integrated with prospective biospecimen collections, omics biomarker analyses and a molecular pathological epidemiology approach, are needed to better understand and manage this disease entity. In this Perspective, we summarize our current understanding of early-onset CRC and discuss how we should strategize future research to improve its prevention and clinical management.

Indexed as

AdolescentAdultAge FactorsAge of OnsetChildChild, PreschoolColorectal NeoplasmsDiet, WesternEarly Detection of CancerFemaleGastrointestinal MicrobiomeGenetic Predisposition to DiseaseHumansIncidenceInfantInfant, Newborn

Identifiers

PMID33219329
PMCPMC7994182
OpenAlexW3100422985

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.